Indices of exhaled breath condensate in children with eosinophilic phenotype of bronchial asthma by Koloskova, O.K. et al.
 27 
Буковинський медичний вісник       Том 17, № 3 (67), ч. 2, 2013 
 
Рецензент – проф. С.Є. Дейнека                              Buk. Med. Herald. – 2013. – Vol. 17, № 3 (67), рart 2. – P. 22-27 
Надійшла до редакції 14.05.2013 року 
 
© Н.А. Каспрук, Л.І. Сидорчук, С.А. Левицька, А.Ю. Михалко, К.І. Яковець,  
Н.М. Довбуш, А.С. Сидорчук, О.А. Іфтодій, І.Й. Сидорчук, 2013 
5. Boyton R.J. Pulmonary defenses to acute respiratory in-
fection / K.J. Boyton, P.J. Openshaw // British 
Med.Bulletin. – 2002. – Vol. 61, № 3. – P. 1-12. 
6. Bergey’s Manual of Systematic Bacteriology. 2-nd.ed. / 
D.R. Boone, R.W. Gastenhdz, M. George [et al.]. – New 
York: Springer – Verlag. 2001. – 679 p. 
7. Dobler G. Recent taxonomic changes and up date of no-
menclature for bacteria identified in clinical material /  
G. Dobler, J. Braveny // Eur. J. Clin. Microbiology Infect. 
Dis. – 2003. – Vol. 22. – P. 643-646. 
8. Manual of clinical microbiology / P.R. Murray,  
E.I. Baron, I.H. Jorgensen [et al.]. – Washington: ASM 
Press. – 2003. – 517 p. 
9. UNICEF/WHO. Pneumonia: The forgotten killer of chil-
dren. – Geneva, 2006. – 42 p. 
ВЕДУЩИЕ ВОЗБУДИТЕЛИ ВНЕГОСПИТАЛЬНОЙ ПНЕВМОНИИ И ИХ  
ИММУНОСУПРЕССИВНЫЕ СВОЙСТВА 
Н.А. Каспрук, Л.И. Сидорчук, С.А. Левицкая, А.Ю. Михалко, К.И. Яковец,  
Н.М. Довбуш, А.С. Сидорчук, О.А. Ифтодий, И.Й. Сидорчук 
Резюме. Внегоспитальная пневмония развивается на фоне нарушенного микробиоценоза полости ротоглотки 
ІІ-ІІІ степеней за счет элиминации из биотопа или формирования дефицита автохтонных облигатных анаэробных 
(Lactobacillus spp.), факультативных анаэробных и аэробных бактерий (S. salivarius, L. lactis); контаминации и уве-
личения количества в биотопе условно-патогенных (S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus, K. pneu-
moniae) бактерий. Ведущими возбудителями внегоспитальной пневмонии на современном этапе являются S. pneu-
moniae (55,55 %), H. influenzae (22,22 %), M. catarrhalis (14,82 %), S. aureus, K. pneumoniae. Возбудители проявляют 
антилизоцимную, антикомплементарную и антиимуноглобулиновую (IgM, IgG, IgA) активность.  
Ключевые слова: внегоспитальная пневмония, микрофлора, иммуносупрессивные особенности. 
THE PROMINENT PATHOGENS OF COMMUNITY-ACQUIRED PNEUMONIA AND  
THEIR IMMUNE-DEPRESSIVE PROPERTIES 
N.A. Kaspruck, L.I. Sydorchuk, S.A. Levytska, A.Yu. Michalko, K.I. Yakovec,  
N.M. Dovbusch, A.S. Sydorchuk, O.A. Iftodiy, I.Y. Sydorchuk 
Abstract. The community-acquired pneumonia develops on the background of II-III degrees violation of microbio-
cenosis of orhopharynx due to elimination or development of deficit of obligatory anaerobic and aerobic bacteria 
(Lactobacillus spp.), facultative anaerobic and aerobic bacteria (S. salivarius, L. lactis); due to contamination and increasing 
the amount of conditionally pathogenic (S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus, K. pneumoniae) bacteria. 
The prominent pathogens of out-hospital pneumonia were S. pneumoniae (55,55 %), H. influenzae (22,22 %), M. catar-
rhalis (14,82 %), S. aureus, K. pneumoniae. The pathogens had anti-lysozyme, anti-complement and anti-immunoglobulin 
(IgM, IgG, IgA) activity.  
Key words: community-acquired pneumonia, microflora, immune-depressive properties. 
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INDICES OF EXHALED BREATH CONDENSATE IN CHILDREN WITH  
EOSINOPHILIC PHENOTYPE OF BRONCHIAL ASTHMA 
Bukovinian State Medical University, Chernivtsy city, Ukraine 
Summary. The indices of exhaled air condensate 
have been studied in 160 children with different phenotypes 
of bronchial asthma. It has been demonstrated that there 
occur changes in children with the noneosinophilic pheno-
type of bronchial asthma as compared with the patients 
with the eosinophilic phenotype of the disease that are in-
dicative of a higher activity of inflammatory processes in 
the respiratory tracts. The proteolytic activity according to 
azocasein lysis more than 1,5 ml/h had the highest diagnos-
tic value of detection of noneosinophilic phenotype: spesi-
phity 84,7 %, the predictable value of a positive result 
79,1 %, the odds ratio 7,5, the posttesting probability of 
positive result 79,1 %. 
Key words: children, bronchial asthma, exhaled 
breath condensate. 
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Introduction. Currently, bronchial asthma in 
children is considered as a disease characterized by 
chronic inflammation of the airways, in development 
of which many different cells and cellular elements 
play the role [6]. It is believed that under the anti-
genic stimulation the primary effectors’ cells 
(epithelial cells of the respiratory tract, mast cells, 
and macrophages) associated with Ig E, release in-
flammatory mediators, causing a development of 
inflammatory reaction both immediate  and late type. 
The main mediators that initiate the acute phase 
of inflammation are interleukins, tumor necrosis fac-
tor-α, interferon-γ, which activate a cascade of im-
munological reactions and promote access to the 
peripheral circulation of histamine, leukotrienes and 
chemotaxics factors of eosinophils and neutrophils as 
well as other inflammatory mediators [1]. 
Recently the first results of study researches of 
these processes in biological fluids such as exhaled 
breath condensate or saliva that can be obtained by 
non-invasive methods,  have been appeared [7, 8]. It 
has been studied that under bronchial asthma consid-
erable changes in exhaled breath condensate ap-
peared, including its physical and chemical proper-
ties, acid-base balance, accumulation both nitric ox-
ide and hydrogen peroxide, as well as aldehydes, 
prostanoids and cytokines [5, 9, 10]. 
However, most studies of exhaled breath con-
densate have been carried out in adults, but in chil-
dren are almost absent, which assign the topicality of 
this research, aimed at  study of inflammatory proc-
esses and improvement of individualized treatment 
for children with different phenotypes of bronchial 
asthma.  
The aim of the research. To study indices of 
exhaled breath condensate at eosinophilic and 
noneosinophilic phenotypes of bronchial asthma in 
school age children. 
Patients and methods. To achieve the aim, of 
the study, the examination of 160 school age chil-
dren with bronchial asthma (BA), which received in-
patient treatment in the regional children's hospital in 
Chernivtsi, has been performed. The clinical 
comparison group were formed according to the 
number of eosinophils in the sputum of patients by 
the classification of P. Haldar and I. Pavord (2007): 
patients with presence of 3 % or more of eosinophils 
in sputum were attributed to the eosinophilic pheno-
type of BA, but children with the number of eosino-
phils in the sputum less than 3 % were ascribed to 
noneosinophilic asthma phenotype.   
To the I group 84 children with eosinophilic 
phenotype of BA were referred, and II comparison 
group was formed by 76 patients with noneosino-
philic asthma phenotype. The average age of chil-
dren of the I group was 11,8±0,4 years (73,8 % of 
boys and 44,0 % of rural population), in the II com-
parison group the average age of patients was 
11,1±0,4 years (57,9 % of boys and 43,4 % of rural 
population), that is clinical group were comparable 
by the main clinical characteristics. 
Exhaled breath condensate (EBC) was collected 
for 15-20 min. using self-designed condenser (patent 
№ 45346 UA A61V 5/08, filed: 10.11.2009). 
The complex study of exhaled breath conden-
sate included: determination of level of nitrogen 
monoxide metabolites [2], determination of total 
protein by the method of Lowry OH, content of both 
basic and neutral aldehyde- and ketone- derivatives 
of 2,4-dinitrophenylhydrazines (AKDNPH) [3]; pro-
teolytic activity by lysis of azoalbumin, azocasein 
and azocollagen [4], catalytic activity [4]. 
Obtained results were analyzed using the soft-
ware package «STATISTICA 7.0» StatSoft Inc. by 
means of parametric methods of calculation as well 
as methods of biostatistics and clinical epidemiology 
with the evaluation of indices’ diagnostic value. 
Results. Table 1 shows the results of analysis of 
indices of oxidative modification of proteins in ex-
haled breath condensate of children in the compari-
son group. 
These results suggest that the content of total 
protein, AKDNPH both neutral and basic character 
was slightly higher in patients with noneosinophilic 
asthma, reflecting the greater activity of the airways’ 
inflammatory process under that phenotype of dis-
ease. Thus, the fraction of children with noneosino-
phiic type of bronchial inflammation that had in EBC 
the level of basic AKDNPH more than 50 millimole/
g of protein was 53,6 % compared to 33,3 % in the I 
comparison group. Despite on absence of significant 
difference at comparison groups according to the 
content of basic AKDNPH in exhaled breath conden-
sate of children, the level of this indicator less than 
50.0 50 millimole/g of protein allowed to verify the 
presence of eosinophilic phenotype of BA by a sensi-
tivity of 70,8%, odds ratio 1,8 and positive post test 
probability 55,2 %. 
In children with eosinophilic BA there has been 
noticed following proteolytic activities by lysis of: 
azoalbumin (1,45±0,07 ml/h), azocasein (1,25±0,06 
ml/h) and azocollagen – 0,2±0,02 ml/h. In the com-
parison group, these indices of proteolysis were 
accordingly: 1,45±0,05 ml/h (p>0,05); 1,5±0,05 ml/h 
(p<0,05) and 0,19±0,02 (p>0,05). The research re-
sults give reason to believe that the proteolytic activ-
ity by lysis of azocasein was significantly higher in 
patients with noneosinophilic asthma, probably due 
to the greater degree of inflammation of the bronchi. 
Thus, such index of EBC as the proteolytic activity 
by azocasein lysis in the meaning of more than 1,5 ml/h 
was registered in 47,4 % of patients with noneosino-
philic asthma phenotype in comparison to 15,4 % of 
children with eosinophilic type of the bronchial inflam-
mation. Diagnostic value of that test’s result in confir-
mation of the noneosinophilic phenotype of BA ran up 
to: specificity 70,8 %, the predictable value of a positive 
result 79,1 %, odds ratio 7,5, the post testing probability 
of positive result 79,1 %. 
Taking into account that intense damage of pro-
teins occurs during asthma exacerbation, studying in 
EBC of fibrinolytic activity markers in children with 
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Table 1 
The content of both total protein and derivatives of proteins’ oxidative modification  







Е 430 millimole/g of protein 
AKDNPH 
neutral type,  
Е 370 millimole/g of protein 
Eosinophilic 3,92±0,29 49,2±6,02 5,56±0,53 
Noneosinophilic 4,15±0,45 63,4±8,05 6,66±0,85 
р р>0,05 р>0,05 р>0,05 
Table 2 
Fibrinolytic activity of exhaled breath condensate in examined children 
Bronchial asthma pheno-
types 




activity Enzymatic  fibrinolytic activity 
Eosinophilic 0,94±0,06 0,43±0,02 0,51±0,05 
Noneosinophilic 0,83±0,03 0,38±0,02 0,47±0,02 
р >0,05 >0,05 >0,05 
different types of airways’ inflammation considered 
as worthwhile. Table 2 shows the indices of fibri-
nolytic activity in exhaled breath condensate of chil-
dren at the comparison.groups. 
The total fibrinolytic activity of EBC in patients 
of ІІ group more than 0,94 mcg of azofibrin/ml/h 
was determined in 30,8 % of cases, but in children of 
comparison group – in 21,0 % of cases. Non-
enzymatic fibrinolytic activity of exhaled breath con-
densate that exceed 0.48 mcg of azofibrin/ml/h was 
observed in 30,8 % of patients with eosinophilic 
asthma phenotype, but in the comparison group – 
only in 15,8 % of cases (pφ>0,05). 
In view of free radicals that are produced due to 
excessive oxidative stress in the airways, may par-
ticipate in the development of bronchial obstruction 
during asthma exacerbation, assessment of antioxi-
dant status in the examined children seemed to be 
appropriate. Therefore, catalase activity as a major 
intracellular antioxidant enzyme, was defined in ex-
haled breath condensate. 
Thus, catalase activity in EBC was at the mean 
54,9±10,42 micromole/min × mg of protein in pa-
tients with eosinophilic inflammation of the airways, 
but  38.3 ± 7,52 micromole/min × mg of protein 
(p>0,05) under noneosinophilic type of bronchial 
inflammation. Diagnostic value of detecting eosino-
philic asthma phenotype by the activity of catalase 
more than 60.0 micromole/min × mg of protein in 
exhaled breath condensate came to: specificity of 
82,6 %, odds ratio 1,7, post test probability of 
59,8 %. 
It has been noted that the content of nitrogen 
monoxide metabolites in EBC of children in the 
clinical groups hardly differed and was at the mean 
46,4±4,33 micromole/L in patients with eosinophilic 
phenotype of BA and 46,7±3,32 micromole/L (p> 
0,05) under noneosinophilic asthma phenotype. Al-
though there has been no significant difference on 
the content of nitrogen monoxide in exhaled breath 
condensate of children at comparison group, the 
level of this index more than 55,0 micromole/L con-
firmed eosinophilic asthma phenotypes with a speci-
ficity of 78,6 % and odds ratio=1,1. 
Analysis of the data has been showed that al-
most all of the mentioned indices had sufficient 
specificity but low sensitivity regarding detection of 
eosinophilic phenotype of BA. At the same time, 
their likelihood ratio remains quite far from the re-
quirements that apply to the current diagnostic tests. 
Moreover, findings suggest that usage of such a 
well-known index of airways’ inflammation as nitric 
oxide metabolites in EBC, is inexpedient for risk 
assessment of occurrence of eosinophilic asthma 
phenotype in school age patients. 
Conclusions  
1. Marked changes that indicate less active in-
flammation of airways have been recorded in ex-
haled breath condensate of children with eosinophilic 
asthma phenotype in comparison with patients with 
noneosinophilic phenotype of the disease.  
2. Indices of exhaled breath condensate can be 
used for confirmation of eosinophilic bronchial 
asthma phenotype only as additional markers. 
Future trends of research is to study spiromet-
rical indices under the eosinophilic asthma pheno-
type in school age children. 
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ПОКАЗАТЕЛИ КОНДЕНСАТА ВЫДЫХАЕМОГО ВОЗДУХА У ДЕТЕЙ  
С ЭОЗИНОФИЛЬНЫМ ФЕНОТИПОМ БРОНХИАЛЬНОЙ АСТМЫ 
Е.К. Колоскова, Л.В. Микалюк, Т.М. Билоус, Е.П. Ортеменка 
Резюме. Изучали показатели конденсата выдыхаемого воздуха у 160 детей, больных бронхиальной астмой, 
при разных фенотипах заболевания. Показано, что у детей с неэозинофильным фенотипом бронхиальной астмы по 
сравнению с пациентами с эозинофильным фенотипом заболевания в конденсате выдыхаемого воздуха отмечаются 
изменения, которые подтверждают большую активность воспаления бронхов. Наибольшую диагностическую цен-
ность выявления неэозинофильного фенотипа с определенных показателей имела протеолитическая активность по 
лизису азоказеина больше 1,5 мл/час: специфичность 84,7 %, предсказуемая ценность положительного результата 
79,1 %, соотношение шансов 7,5, посттестовая вероятность положительного результата 79,1 %. 
Ключевые слова: дети, бронхиальная астма, конденсат выдыхаемого воздуха. 
ПОКАЗНИКИ КОНДЕНСАТУ ВИДИХУВАНОГО ПОВІТРЯ У ДІТЕЙ  
ЗА ЕОЗИНОФІЛЬНОГО ФЕНОТИПУ БРОНХІАЛЬНОЇ АСТМИ  
O.К. Колоскова, Л.В. Микалюк, Т.М. Білоус, Є.П. Ортеменка 
Резюме. Вивчали показники конденсату видихуваного повітря у 160 хворих на бронхіальну астму за різних 
фенотипів захворювання. Показано, що в дітей із нееозинофільним фенотипом бронхіальної астми порівняно із 
пацієнтами з еозинофільним фенотипом захворювання у конденсаті видихуваного повітря відмічаються зміни, які 
свідчать про більшу активність запальних процесів бронхів. Найвищу діагностичну цінність виявлення нееозинофі-
льного фенотипу астми з вивчених показників відмічено за протеолітичною активністю за лізисом азоказеїну в 
конденсаті видихуваного повітря більше 1,5 мл/год: специфічність 84,7%, передбачувана цінність позитивного 
результату 79,1 %, співвідношення шансів 7,5, посттестова вірогідність 79,1 %. 
Ключові слова: діти, бронхіальна астма, конденсат видихуваного повітря. 
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